Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Current Neuropharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
CN
Current Neuropharmacology is a journal in neuropharmacology with ISSN (Print) 1570-159X and ISSN (Online) 1875-6190. It publishes Volume 24 in 2026, has a current Impact Factor of 5.3, a 5-year Impact Factor of 7.4, and a CiteScore of 10.0. Open access articles are also available on ScienceDirect.
Looking to publish in Current Neuropharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite Now
Subject
Neurosciences, Pharmacology & Pharmacy
Impact Factor
5.3
Quartile
Q1
Open Access Type
Hybrid
ISSN
1570-159X
eISSN
1875-6190
Invitation Only
No
Cost Range
Publication is supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.
Submission Instructions
Current Neuropharmacology accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Cover Letter
A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The copyright letter must include signatures from all contributing authors, and all co-authors must declare full responsibility for the manuscript contents including any AI-generated content.
Abstract
Review Articles must include a structured abstract. Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript
Review Articles must be 6000-10000 words, excluding figures, structures, photographs, schemes, and tables. Review Articles must be divided into Title, Title page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations (if any), Consent for Publication, Conflict of Interest, Acknowledgements, References, Appendices, Figures/Illustrations (if any), Chemical Structures (if any), Tables (if any), and Supportive/Supplementary Material (if any). Manuscripts must include a graphical abstract submitted separately, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict-of-interest summary statement, and disclosure of any significant AI use.
References
Review Articles must include 100 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and the bibliography must be complete, accurate, and fully formatted before submission.
Figures & Tables
Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript, while the graphical abstract must be submitted separately. Figures and tables must be numbered consecutively in order of citation, each table must include a self-explanatory title or caption, and figure legends and captions must be provided.
Mini-Reviews
Cover Letter
A signed copyright letter must be submitted with the manuscript. The corresponding author must submit the copyright letter on behalf of all co-authors, and all co-authors must sign a declaration accepting full responsibility for all manuscript contents including any AI-generated content.
Abstract
An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript
Mini-Reviews must be 3000-6000 words, excluding figures, structures, photographs, schemes, and tables. Section headings must be numbered sequentially and start with the introduction. The manuscript must include a graphical abstract submitted separately, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict of interest statement, and disclosure of any significant use of AI tools.
References
Mini-Reviews must include 75 or more references. References should be prepared preferably in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and the reference list must exclude abstracts, unpublished data, and personal communications.
Figures & Tables
Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript. Each table must include a self-explanatory title or caption, and each figure must be numbered consecutively and include a legend or caption.
Systematic Reviews
Cover Letter
Cover Letter requirements are not specified.
Abstract
A structured abstract is required for Systematic Reviews. Abstract must not exceed 250 words. Abstract must be structured. Abstract should use subheadings such as Introduction/Objective, Methods, Results, Discussion, and Conclusion, and registered systematic reviews must include the registration number as the last line of the abstract.
Manuscript
Manuscript must be 4000–6000 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must address the methods used for selecting, locating, extracting, and synthesizing data. Manuscript must include 6 to 8 keywords, a graphical abstract, conflict of interest summary statement, an Authors' Contribution paragraph, a CRediT author statement, and disclosure of any significant AI tool use.
References
Systematic Reviews must include 100 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and listed as complete and fully formatted entries.
Figures & Tables
Figures and tables must be embedded in the text at their appropriate placement in the manuscript. Each table must include a self-explanatory title or caption, and each figure must include a legend or caption and be numbered consecutively in order of appearance.
Research Articles
Cover Letter
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must include declarations that all authors approved the submission and publication of all versions of the manuscript and that all co-authors take full responsibility for the manuscript contents, including any AI-generated content.
Abstract
Research Articles must include a structured abstract. The structured abstract must not exceed 250 words. The abstract must be structured. The structured abstract should use subheadings such as Introduction/Objective, Methods, Results, Discussion, and Conclusion.
Manuscript
Research Articles must be 4000-6000 words, excluding figures, structures, photographs, schemes, and tables. The main text must be organized as Introduction, Materials and Methods, Results, Discussion, and Conclusion, and Research Articles must begin with the title page and abstract followed by the main text. The manuscript must include a graphical abstract, keywords, a List of Abbreviations if any, an Authors' Contribution paragraph with a CRediT author statement, conflict of interest disclosures, and disclosure of significant AI tool use in the manuscript.
References
Research Articles must include 75 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and the reference list must exclude abstracts, unpublished data, and personal communications.
Figures & Tables
Figures and tables must be embedded in the text at the appropriate place where they are first discussed. Figures must be numbered consecutively with legends or captions, and tables must be numbered sequentially in Arabic numerals and include a self-explanatory title or caption.
Randomized Drug Clinical Trial Studies
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract must not exceed 250 words. Abstract must use explicit bold subheadings. The trial registry name, registration identification number, and registry URL must be included at the end of the abstract.
Manuscript
Manuscript must be 4000–6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must clearly state an objective or hypothesis, design and methods, essential features of interventions, main outcome measures, main results, a comment section addressing study limitations and context, conclusions, and a "Randomization and Masking" section within Methods. Manuscript must include a graphical abstract, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict of interest summary statement, disclosure of significant AI use, and trial protocols with the submission.
References
References must total 50 or more. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text with square-bracketed numbers and listed in finalized, fully formatted numerical order.
Figures & Tables
Figures and tables must be embedded in the manuscript text at the appropriate place and cited in sequence. Each figure must include a legend or caption and each table must include a self-explanatory title or caption.
Short Communications
Cover Letter
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Abstract
Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript
Short Communications must be 2000-3000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must include a graphical abstract submitted separately with text not exceeding 30 words, 6 to 8 keywords, an Authors' Contribution paragraph, a CRediT author statement, a conflict of interest statement, and disclosure of any significant AI use.
References
Short Communications must include 25 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and listed as complete, accurate, fully formatted entries.
Figures & Tables
Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript, while the graphical abstract must be submitted separately. Each table must include a self-explanatory title or caption, and each figure must have a legend or caption and be numbered consecutively in order of appearance.
Recent Publications
Systematic Reviews and Meta-Analyses of the Use of Tocilizumab in Treating Central Nervous Diseases
Jing Peng, Miriam Kessi, Fei Yin, Lifen Yang
10.2174/011570159x416346251202083137
View Publication
Cryptotanshinone and Its Metabolite Ameliorate Rewarding Effect of Nitrous Oxide via Nucleus Accumbens D1 Receptor and TrkB Pathway
Sheng-Nan Liu, Wen-Qi Li, Si-Chang Yang, Yan-Yan Chen, Chun-Yuan Chiang, Zhang-Jin Zhang
10.2174/011570159x430063260112070645
View Publication
Neuro-navigated rTMS Targeting Left Angular Gyrus Promotes White-Gray Matter Remodelling to Improve Cognitive Function in Amnestic Mild Cognitive Impairment Patients: Evidence for Early Alzheimer.s Intervention
Zhiyuan Yang, Xinle Hou, Yi Tan, Limoran Tang, Zhihong Ke, Zheqi Hu, Qing Ye, Hailan Meng, Yun Xu, Haifeng Chen
10.2174/011570159x438627260121063828
View Publication
Exploring Genetic and Epigenetic Interplay: Novel Therapeutic Targets for Disability Management
Qazi Mohammad Sajid Jamal, Ali H Alharbi, Varish Ahmad, Khurshid Ahmad
10.2174/011570159x430189260311013603
View Publication
Exploring the Influence of Inflammation on the Pharmacokinetics of Antidepressants and Antipsychotics: A Systematic Review
Giuseppe Cicala, Maria Antonietta Barbieri, Alessandro Gialluisi, Letizia Scandiffio, Nadia Cattane, Annamaria Cattaneo, Francesco Benedetti, Massimo Gennarelli, Georgios Schoretsanitis, Jose de Leon, Edoardo Spina
10.2174/011570159x465955260311043235
View Publication
Frequently asked questions
How long does it take to publish?
Authors are usually requested to resubmit revised papers within 15 days. The time frame for revision may vary from one to four weeks depending on the revision required. QUICK TRACK allows online publication within 2 weeks of receipt of the final approved galley proofs, with total publication time from first receipt of the manuscript to online publication of 10 weeks, subject to acceptance and author revisions within one week.
Reformat to Current Neuropharmacology using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to Current Neuropharmacology using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access articles.
Reformat to Current Neuropharmacology using Livewrite PremiumResearch Topics
Neuroscience and Neuropharmacology Research
Tryptophan and brain disorders
Neurotransmitter Receptor Influence on Behavior
Alzheimer's disease research and treatments
Neuroinflammation and Neurodegeneration Mechanisms
Cholinesterase and Neurodegenerative Diseases
Stress Responses and Cortisol
Treatment of Major Depression
Parkinson's Disease Mechanisms and Treatments
Diverse Scientific and Economic Studies
Pain Mechanisms and Treatments
Nicotinic Acetylcholine Receptors Study
Schizophrenia research and treatment
Epilepsy research and treatment
Cannabis and Cannabinoid Research
14-3-3 protein interactions
Receptor Mechanisms and Signaling
Mitochondrial Function and Pathology
Cancer Mechanisms and Therapy
Ion channel regulation and function
Neurological disorders and treatments
Bipolar Disorder and Treatment
Neurological Disease Mechanisms and Treatments
Neurogenesis and neuroplasticity mechanisms
Pharmacological Receptor Mechanisms and Effects